|20.00||+0.8700||+4.55%||Vol 339.59K||1Y Perf -54.57%|
|Jun 27th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||25.30||Analyst Rating||Moderate Sell 3.60|
|Potential %||26.50||Finscreener Ranking||☆ 30.66|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||☆ 30.18|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★ 36.64|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||☆ 17.19|
|Price Range Ratio 52W %||6.39||Earnings Rating||Strong Sell|
|Market Cap||926.48M||Earnings Date||27th Jul 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||27th Jul 2022|
|Estimated EPS Next Report||0.14|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||429.20K|
|Avg. Monthly Volume||462.06K|
|Avg. Quarterly Volume||478.13K|
Core Laboratories N.V. (NYSE: CLB) stock closed at 20 per share at the end of the most recent trading day (a 4.55% change compared to the prior day closing price) with a volume of 339.59K shares and market capitalization of 926.48M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Oil & Gas industry, Energy sector and employs 3700 people. Core Laboratories N.V. CEO is Lawrence Bruno.
The one-year performance of Core Laboratories N.V. stock is -54.57%, while year-to-date (YTD) performance is -10.35%. CLB stock has a five-year performance of -79.87%. Its 52-week range is between 18.41 and 43.3, which gives CLB stock a 52-week price range ratio of 6.39%
Core Laboratories N.V. currently has a PE ratio of 91.10, a price-to-book (PB) ratio of 5.48, a price-to-sale (PS) ratio of 1.94, a price to cashflow ratio of 26.40, a PEG ratio of 2.32, a ROA of 1.71%, a ROC of 3.84% and a ROE of 6.58%. The company’s profit margin is 2.10%, its EBITDA margin is 10.80%, and its revenue ttm is $477.17 Million , which makes it $10.30 revenue per share.
Of the last four earnings reports from Core Laboratories N.V., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.14 for the next earnings report. Core Laboratories N.V.’s next earnings report date is 27th Jul 2022.
The consensus rating of Wall Street analysts for Core Laboratories N.V. is Moderate Sell (3.6), with a target price of $25.3, which is +26.50% compared to the current price. The earnings rating for Core Laboratories N.V. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Core Laboratories N.V. has a dividend yield of 0.20% with a dividend per share of $0.04 and a payout ratio of 9.00%.
Core Laboratories N.V. has a Sell technical analysis rating based on Technical Indicators (ADX : 8.68, ATR14 : 1.56, CCI20 : -110.69, Chaikin Money Flow : -0.13, MACD : -2.06, Money Flow Index : 27.70, ROC : -38.33, RSI : 28.76, STOCH (14,3) : 5.53, STOCH RSI : 0.44, UO : 32.65, Williams %R : -94.47), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Core Laboratories N.V. in the last 12-months were: Gregory B. Barnett (Option Excercise at a value of $0), Harvey Klingensmith (Option Excercise at a value of $0), Kevin Daniels (Option Excercise at a value of $0), Kwaku Temeng (Option Excercise at a value of $0), Mark Damian Tattoli (Option Excercise at a value of $0), Martha Z. Carnes (Option Excercise at a value of $0), Michael Straughen (Option Excercise at a value of $0), Monique van Dijken Eeuwijk (Option Excercise at a value of $0)
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.